Morgan Amsler

Morgan Amsler has 11+ years of experience leading mid-market life science and medical device business growth initiatives including sales, corporate strategy, and new business development. At Apiject, Mr. Amsler will lead business development efforts in the U.S. as well as manage licensing agreements for the Apiject Platform of technologies to companies developing injectable vaccines, generics, new chemical entities, and biosimilar therapeutics.

Morgan was Vice President of Sales & Business Development and an Executive Board Member for Arcmed, a subsidiary company of Halma plc. He managed organic and acquired growth initiatives and strategy through the integration and transformation of two leading life science manufacturers. Previously, Mr. Amsler served as Director of Business Development where he managed business development, valuation, negotiations, and acquisition for ophthalmic devices at Microsurgical Technologies. Previous positions include Director of Innovation for Halma Healthcare Sector, New Product Development Manager for Acutome, and a Founding Member of the Futures Leaders Program at Halma. Mr. Amsler earned his MBA from Columbia Business School and a Bachelor’s Degree with a focus on Biomedical Engineering from Vanderbilt University.